nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminocaproic Acid—PLG—ovarian follicle—ovarian cancer	0.111	0.278	CbGeAlD
Aminocaproic Acid—PLG—vein—ovarian cancer	0.0792	0.198	CbGeAlD
Aminocaproic Acid—PLG—embryo—ovarian cancer	0.015	0.0376	CbGeAlD
Aminocaproic Acid—PLAT—myometrium—ovarian cancer	0.0132	0.0332	CbGeAlD
Aminocaproic Acid—PLG—epithelium—ovarian cancer	0.0122	0.0306	CbGeAlD
Aminocaproic Acid—PLG—endometrium—ovarian cancer	0.011	0.0275	CbGeAlD
Aminocaproic Acid—PLAT—uterine cervix—ovarian cancer	0.0103	0.0258	CbGeAlD
Aminocaproic Acid—PLG—gonad—ovarian cancer	0.0102	0.0255	CbGeAlD
Aminocaproic Acid—PLG—uterus—ovarian cancer	0.0101	0.0253	CbGeAlD
Aminocaproic Acid—PLAT—decidua—ovarian cancer	0.00982	0.0246	CbGeAlD
Aminocaproic Acid—PLAT—endometrium—ovarian cancer	0.00932	0.0234	CbGeAlD
Aminocaproic Acid—PLG—female reproductive system—ovarian cancer	0.00908	0.0228	CbGeAlD
Aminocaproic Acid—PLAT—uterus—ovarian cancer	0.00859	0.0215	CbGeAlD
Aminocaproic Acid—PLG—female gonad—ovarian cancer	0.00826	0.0207	CbGeAlD
Aminocaproic Acid—PLG—testis—ovarian cancer	0.00733	0.0184	CbGeAlD
Aminocaproic Acid—AOX1—myometrium—ovarian cancer	0.00716	0.0179	CbGeAlD
Aminocaproic Acid—PLAT—female gonad—ovarian cancer	0.00703	0.0176	CbGeAlD
Aminocaproic Acid—PLAT—vagina—ovarian cancer	0.00698	0.0175	CbGeAlD
Aminocaproic Acid—PLAT—testis—ovarian cancer	0.00623	0.0156	CbGeAlD
Aminocaproic Acid—AOX1—uterine cervix—ovarian cancer	0.00557	0.014	CbGeAlD
Aminocaproic Acid—AOX1—decidua—ovarian cancer	0.00531	0.0133	CbGeAlD
Aminocaproic Acid—AOX1—endometrium—ovarian cancer	0.00504	0.0126	CbGeAlD
Aminocaproic Acid—AOX1—gonad—ovarian cancer	0.00467	0.0117	CbGeAlD
Aminocaproic Acid—AOX1—uterus—ovarian cancer	0.00464	0.0116	CbGeAlD
Aminocaproic Acid—PLAT—lymph node—ovarian cancer	0.00452	0.0113	CbGeAlD
Aminocaproic Acid—AOX1—female reproductive system—ovarian cancer	0.00417	0.0105	CbGeAlD
Aminocaproic Acid—Pulmonary embolism—Topotecan—ovarian cancer	0.00408	0.0127	CcSEcCtD
Aminocaproic Acid—Injection site reaction—Melphalan—ovarian cancer	0.00397	0.0123	CcSEcCtD
Aminocaproic Acid—AOX1—female gonad—ovarian cancer	0.0038	0.00952	CbGeAlD
Aminocaproic Acid—AOX1—vagina—ovarian cancer	0.00377	0.00946	CbGeAlD
Aminocaproic Acid—Pulmonary embolism—Vinorelbine—ovarian cancer	0.00349	0.0108	CcSEcCtD
Aminocaproic Acid—Injection site reaction—Vinorelbine—ovarian cancer	0.00347	0.0108	CcSEcCtD
Aminocaproic Acid—AOX1—testis—ovarian cancer	0.00337	0.00844	CbGeAlD
Aminocaproic Acid—Thrombosis—Paclitaxel—ovarian cancer	0.00331	0.0103	CcSEcCtD
Aminocaproic Acid—Anaphylactoid reaction—Topotecan—ovarian cancer	0.00306	0.0095	CcSEcCtD
Aminocaproic Acid—Dizziness—Altretamine—ovarian cancer	0.00304	0.00944	CcSEcCtD
Aminocaproic Acid—Necrosis—Paclitaxel—ovarian cancer	0.00299	0.00928	CcSEcCtD
Aminocaproic Acid—Vomiting—Altretamine—ovarian cancer	0.00292	0.00908	CcSEcCtD
Aminocaproic Acid—Myositis—Epirubicin—ovarian cancer	0.00273	0.00849	CcSEcCtD
Aminocaproic Acid—Nausea—Altretamine—ovarian cancer	0.00273	0.00848	CcSEcCtD
Aminocaproic Acid—Pain—Carboplatin—ovarian cancer	0.00272	0.00844	CcSEcCtD
Aminocaproic Acid—Cerebrovascular accident—Vinorelbine—ovarian cancer	0.00258	0.00803	CcSEcCtD
Aminocaproic Acid—Lacrimation increased—Paclitaxel—ovarian cancer	0.00254	0.00791	CcSEcCtD
Aminocaproic Acid—Necrosis—Docetaxel—ovarian cancer	0.00253	0.00787	CcSEcCtD
Aminocaproic Acid—Myositis—Doxorubicin—ovarian cancer	0.00253	0.00786	CcSEcCtD
Aminocaproic Acid—AOX1—lymph node—ovarian cancer	0.00244	0.00612	CbGeAlD
Aminocaproic Acid—Local reaction—Epirubicin—ovarian cancer	0.00242	0.00752	CcSEcCtD
Aminocaproic Acid—Pulmonary embolism—Paclitaxel—ovarian cancer	0.00235	0.00729	CcSEcCtD
Aminocaproic Acid—Injection site reaction—Paclitaxel—ovarian cancer	0.00233	0.00724	CcSEcCtD
Aminocaproic Acid—Hallucination—Chlorambucil—ovarian cancer	0.00229	0.00711	CcSEcCtD
Aminocaproic Acid—Local reaction—Doxorubicin—ovarian cancer	0.00224	0.00696	CcSEcCtD
Aminocaproic Acid—Muscular weakness—Vinorelbine—ovarian cancer	0.00223	0.00694	CcSEcCtD
Aminocaproic Acid—Lacrimation increased—Docetaxel—ovarian cancer	0.00216	0.0067	CcSEcCtD
Aminocaproic Acid—Pulmonary embolism—Docetaxel—ovarian cancer	0.00199	0.00618	CcSEcCtD
Aminocaproic Acid—Injection site reaction—Docetaxel—ovarian cancer	0.00198	0.00614	CcSEcCtD
Aminocaproic Acid—Thrombosis—Epirubicin—ovarian cancer	0.00189	0.00589	CcSEcCtD
Aminocaproic Acid—Nasal congestion—Paclitaxel—ovarian cancer	0.00187	0.00581	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Vinorelbine—ovarian cancer	0.00182	0.00566	CcSEcCtD
Aminocaproic Acid—Leukopenia—Chlorambucil—ovarian cancer	0.00179	0.00557	CcSEcCtD
Aminocaproic Acid—Thrombosis—Doxorubicin—ovarian cancer	0.00175	0.00545	CcSEcCtD
Aminocaproic Acid—Cerebrovascular accident—Paclitaxel—ovarian cancer	0.00174	0.0054	CcSEcCtD
Aminocaproic Acid—Convulsion—Chlorambucil—ovarian cancer	0.00173	0.00539	CcSEcCtD
Aminocaproic Acid—Necrosis—Epirubicin—ovarian cancer	0.00171	0.00531	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Topotecan—ovarian cancer	0.00165	0.00514	CcSEcCtD
Aminocaproic Acid—Confusional state—Chlorambucil—ovarian cancer	0.00165	0.00512	CcSEcCtD
Aminocaproic Acid—Malaise—Topotecan—ovarian cancer	0.00161	0.00499	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Chlorambucil—ovarian cancer	0.0016	0.00497	CcSEcCtD
Aminocaproic Acid—Leukopenia—Topotecan—ovarian cancer	0.00159	0.00496	CcSEcCtD
Aminocaproic Acid—Necrosis—Doxorubicin—ovarian cancer	0.00158	0.00491	CcSEcCtD
Aminocaproic Acid—Leukopenia—Melphalan—ovarian cancer	0.00156	0.00485	CcSEcCtD
Aminocaproic Acid—Delirium—Epirubicin—ovarian cancer	0.00156	0.00484	CcSEcCtD
Aminocaproic Acid—Myalgia—Topotecan—ovarian cancer	0.00152	0.00471	CcSEcCtD
Aminocaproic Acid—Convulsion—Melphalan—ovarian cancer	0.00151	0.0047	CcSEcCtD
Aminocaproic Acid—Muscular weakness—Paclitaxel—ovarian cancer	0.0015	0.00467	CcSEcCtD
Aminocaproic Acid—Discomfort—Topotecan—ovarian cancer	0.0015	0.00466	CcSEcCtD
Aminocaproic Acid—Myalgia—Melphalan—ovarian cancer	0.00149	0.00462	CcSEcCtD
Aminocaproic Acid—Lacrimation increased—Epirubicin—ovarian cancer	0.00145	0.00452	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Topotecan—ovarian cancer	0.00145	0.00452	CcSEcCtD
Aminocaproic Acid—Delirium—Doxorubicin—ovarian cancer	0.00144	0.00448	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Melphalan—ovarian cancer	0.00142	0.00442	CcSEcCtD
Aminocaproic Acid—Oedema—Melphalan—ovarian cancer	0.00142	0.00442	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Topotecan—ovarian cancer	0.00142	0.00442	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Vinorelbine—ovarian cancer	0.00141	0.00439	CcSEcCtD
Aminocaproic Acid—Pain—Chlorambucil—ovarian cancer	0.0014	0.00434	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Melphalan—ovarian cancer	0.00139	0.00433	CcSEcCtD
Aminocaproic Acid—Malaise—Vinorelbine—ovarian cancer	0.00137	0.00427	CcSEcCtD
Aminocaproic Acid—Leukopenia—Vinorelbine—ovarian cancer	0.00136	0.00424	CcSEcCtD
Aminocaproic Acid—Lacrimation increased—Doxorubicin—ovarian cancer	0.00135	0.00418	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Chlorambucil—ovarian cancer	0.00135	0.00418	CcSEcCtD
Aminocaproic Acid—Pulmonary embolism—Epirubicin—ovarian cancer	0.00134	0.00417	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00134	0.00415	CcSEcCtD
Aminocaproic Acid—Injection site reaction—Epirubicin—ovarian cancer	0.00133	0.00414	CcSEcCtD
Aminocaproic Acid—Hypotension—Melphalan—ovarian cancer	0.00133	0.00413	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00132	0.00412	CcSEcCtD
Aminocaproic Acid—Myalgia—Vinorelbine—ovarian cancer	0.0013	0.00403	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.0013	0.00403	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Topotecan—ovarian cancer	0.0013	0.00403	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Chlorambucil—ovarian cancer	0.00129	0.00401	CcSEcCtD
Aminocaproic Acid—Renal failure—Paclitaxel—ovarian cancer	0.00129	0.00401	CcSEcCtD
Aminocaproic Acid—Discomfort—Vinorelbine—ovarian cancer	0.00128	0.00398	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Melphalan—ovarian cancer	0.00127	0.00394	CcSEcCtD
Aminocaproic Acid—Blood urea increased—Epirubicin—ovarian cancer	0.00127	0.00393	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00124	0.00387	CcSEcCtD
Aminocaproic Acid—Pain—Topotecan—ovarian cancer	0.00124	0.00386	CcSEcCtD
Aminocaproic Acid—Pulmonary embolism—Doxorubicin—ovarian cancer	0.00124	0.00385	CcSEcCtD
Aminocaproic Acid—Injection site reaction—Doxorubicin—ovarian cancer	0.00123	0.00383	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00122	0.00378	CcSEcCtD
Aminocaproic Acid—Pain—Melphalan—ovarian cancer	0.00122	0.00378	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Chlorambucil—ovarian cancer	0.0012	0.00374	CcSEcCtD
Aminocaproic Acid—Bradycardia—Paclitaxel—ovarian cancer	0.0012	0.00373	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Topotecan—ovarian cancer	0.0012	0.00372	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Topotecan—ovarian cancer	0.00119	0.00369	CcSEcCtD
Aminocaproic Acid—Blood urea increased—Doxorubicin—ovarian cancer	0.00117	0.00364	CcSEcCtD
Aminocaproic Acid—Hypotension—Vinorelbine—ovarian cancer	0.00116	0.00361	CcSEcCtD
Aminocaproic Acid—Pruritus—Chlorambucil—ovarian cancer	0.00116	0.00359	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Topotecan—ovarian cancer	0.00115	0.00357	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00113	0.00352	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Chlorambucil—ovarian cancer	0.00112	0.00347	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Vinorelbine—ovarian cancer	0.00111	0.00345	CcSEcCtD
Aminocaproic Acid—Tinnitus—Paclitaxel—ovarian cancer	0.0011	0.00341	CcSEcCtD
Aminocaproic Acid—Renal failure—Docetaxel—ovarian cancer	0.00109	0.0034	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Topotecan—ovarian cancer	0.00107	0.00333	CcSEcCtD
Aminocaproic Acid—Pain—Vinorelbine—ovarian cancer	0.00106	0.00331	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Melphalan—ovarian cancer	0.00105	0.00326	CcSEcCtD
Aminocaproic Acid—Vomiting—Chlorambucil—ovarian cancer	0.00104	0.00323	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Docetaxel—ovarian cancer	0.00104	0.00322	CcSEcCtD
Aminocaproic Acid—Pruritus—Topotecan—ovarian cancer	0.00103	0.0032	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Vinorelbine—ovarian cancer	0.00103	0.00319	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00102	0.00316	CcSEcCtD
Aminocaproic Acid—Pruritus—Melphalan—ovarian cancer	0.00101	0.00313	CcSEcCtD
Aminocaproic Acid—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.00101	0.00312	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Topotecan—ovarian cancer	0.000995	0.00309	CcSEcCtD
Aminocaproic Acid—Cerebrovascular accident—Epirubicin—ovarian cancer	0.000993	0.00309	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Vinorelbine—ovarian cancer	0.000983	0.00306	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Melphalan—ovarian cancer	0.000974	0.00303	CcSEcCtD
Aminocaproic Acid—Nausea—Chlorambucil—ovarian cancer	0.00097	0.00301	CcSEcCtD
Aminocaproic Acid—PLG—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000968	0.00347	CbGpPWpGaD
Aminocaproic Acid—PLAT—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000968	0.00347	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—IL6ST—ovarian cancer	0.000967	0.00346	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—IL6ST—ovarian cancer	0.000967	0.00346	CbGpPWpGaD
Aminocaproic Acid—Dizziness—Topotecan—ovarian cancer	0.000962	0.00299	CcSEcCtD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—PTEN—ovarian cancer	0.000955	0.00342	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—HSD17B6—ovarian cancer	0.000953	0.00341	CbGpPWpGaD
Aminocaproic Acid—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000951	0.00296	CcSEcCtD
Aminocaproic Acid—PLAT—Folate Metabolism—TP53—ovarian cancer	0.000945	0.00338	CbGpPWpGaD
Aminocaproic Acid—PLG—Folate Metabolism—TP53—ovarian cancer	0.000945	0.00338	CbGpPWpGaD
Aminocaproic Acid—PLG—p75(NTR)-mediated signaling—PIK3CA—ovarian cancer	0.000943	0.00338	CbGpPWpGaD
Aminocaproic Acid—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00093	0.00289	CcSEcCtD
Aminocaproic Acid—Vomiting—Topotecan—ovarian cancer	0.000925	0.00287	CcSEcCtD
Aminocaproic Acid—Malaise—Paclitaxel—ovarian cancer	0.000924	0.00287	CcSEcCtD
Aminocaproic Acid—Syncope—Paclitaxel—ovarian cancer	0.000919	0.00286	CcSEcCtD
Aminocaproic Acid—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.000919	0.00286	CcSEcCtD
Aminocaproic Acid—Leukopenia—Paclitaxel—ovarian cancer	0.000918	0.00285	CcSEcCtD
Aminocaproic Acid—Rash—Topotecan—ovarian cancer	0.000917	0.00285	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Vinorelbine—ovarian cancer	0.000916	0.00285	CcSEcCtD
Aminocaproic Acid—Dermatitis—Topotecan—ovarian cancer	0.000916	0.00285	CcSEcCtD
Aminocaproic Acid—PLG—Signaling Pathways—HSD17B6—ovarian cancer	0.000913	0.00327	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—HSD17B6—ovarian cancer	0.000913	0.00327	CbGpPWpGaD
Aminocaproic Acid—PLG—p75(NTR)-mediated signaling—TP53—ovarian cancer	0.000912	0.00327	CbGpPWpGaD
Aminocaproic Acid—Headache—Topotecan—ovarian cancer	0.000911	0.00283	CcSEcCtD
Aminocaproic Acid—Vomiting—Melphalan—ovarian cancer	0.000905	0.00281	CcSEcCtD
Aminocaproic Acid—Loss of consciousness—Paclitaxel—ovarian cancer	0.000901	0.0028	CcSEcCtD
Aminocaproic Acid—Rash—Melphalan—ovarian cancer	0.000898	0.00279	CcSEcCtD
Aminocaproic Acid—Dermatitis—Melphalan—ovarian cancer	0.000897	0.00279	CcSEcCtD
Aminocaproic Acid—Convulsion—Paclitaxel—ovarian cancer	0.000888	0.00276	CcSEcCtD
Aminocaproic Acid—Pruritus—Vinorelbine—ovarian cancer	0.00088	0.00273	CcSEcCtD
Aminocaproic Acid—PLG—Metabolism of proteins—TUBB3—ovarian cancer	0.000879	0.00315	CbGpPWpGaD
Aminocaproic Acid—Myalgia—Paclitaxel—ovarian cancer	0.000873	0.00271	CcSEcCtD
Aminocaproic Acid—PLAT—Folate Metabolism—IL6—ovarian cancer	0.000865	0.0031	CbGpPWpGaD
Aminocaproic Acid—PLG—Folate Metabolism—IL6—ovarian cancer	0.000865	0.0031	CbGpPWpGaD
Aminocaproic Acid—Nausea—Topotecan—ovarian cancer	0.000864	0.00268	CcSEcCtD
Aminocaproic Acid—Discomfort—Paclitaxel—ovarian cancer	0.000862	0.00268	CcSEcCtD
Aminocaproic Acid—Muscular weakness—Epirubicin—ovarian cancer	0.000858	0.00267	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Vinorelbine—ovarian cancer	0.000851	0.00264	CcSEcCtD
Aminocaproic Acid—PLAT—Hemostasis—SPARC—ovarian cancer	0.000847	0.00303	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—SPARC—ovarian cancer	0.000847	0.00303	CbGpPWpGaD
Aminocaproic Acid—Nausea—Melphalan—ovarian cancer	0.000846	0.00263	CcSEcCtD
Aminocaproic Acid—Confusional state—Paclitaxel—ovarian cancer	0.000844	0.00262	CcSEcCtD
Aminocaproic Acid—Oedema—Paclitaxel—ovarian cancer	0.000837	0.0026	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000837	0.0026	CcSEcCtD
Aminocaproic Acid—Shock—Paclitaxel—ovarian cancer	0.000823	0.00256	CcSEcCtD
Aminocaproic Acid—Dizziness—Vinorelbine—ovarian cancer	0.000823	0.00256	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000819	0.00255	CcSEcCtD
Aminocaproic Acid—PLAT—Endochondral Ossification—AKT1—ovarian cancer	0.000818	0.00293	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—PIK3CD—ovarian cancer	0.000817	0.00292	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—PIK3CD—ovarian cancer	0.000817	0.00292	CbGpPWpGaD
Aminocaproic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	0.000795	0.00285	CbGpPWpGaD
Aminocaproic Acid—Muscular weakness—Doxorubicin—ovarian cancer	0.000794	0.00247	CcSEcCtD
Aminocaproic Acid—Vomiting—Vinorelbine—ovarian cancer	0.000791	0.00246	CcSEcCtD
Aminocaproic Acid—Rash—Vinorelbine—ovarian cancer	0.000784	0.00244	CcSEcCtD
Aminocaproic Acid—Dermatitis—Vinorelbine—ovarian cancer	0.000784	0.00243	CcSEcCtD
Aminocaproic Acid—Hypotension—Paclitaxel—ovarian cancer	0.000782	0.00243	CcSEcCtD
Aminocaproic Acid—Headache—Vinorelbine—ovarian cancer	0.000779	0.00242	CcSEcCtD
Aminocaproic Acid—Syncope—Docetaxel—ovarian cancer	0.000779	0.00242	CcSEcCtD
Aminocaproic Acid—Leukopenia—Docetaxel—ovarian cancer	0.000778	0.00242	CcSEcCtD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—MAPK1—ovarian cancer	0.000777	0.00278	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—DLC1—ovarian cancer	0.000776	0.00278	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—DLC1—ovarian cancer	0.000776	0.00278	CbGpPWpGaD
Aminocaproic Acid—PLG—p75(NTR)-mediated signaling—AKT1—ovarian cancer	0.00077	0.00276	CbGpPWpGaD
Aminocaproic Acid—Loss of consciousness—Docetaxel—ovarian cancer	0.000764	0.00237	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000762	0.00237	CcSEcCtD
Aminocaproic Acid—AOX1—Disease—CHMP4C—ovarian cancer	0.000762	0.00273	CbGpPWpGaD
Aminocaproic Acid—Convulsion—Docetaxel—ovarian cancer	0.000753	0.00234	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Paclitaxel—ovarian cancer	0.000746	0.00232	CcSEcCtD
Aminocaproic Acid—PLG—Metabolism of proteins—ATF3—ovarian cancer	0.000742	0.00266	CbGpPWpGaD
Aminocaproic Acid—Myalgia—Docetaxel—ovarian cancer	0.00074	0.0023	CcSEcCtD
Aminocaproic Acid—Nausea—Vinorelbine—ovarian cancer	0.000739	0.0023	CcSEcCtD
Aminocaproic Acid—Renal failure—Epirubicin—ovarian cancer	0.000737	0.00229	CcSEcCtD
Aminocaproic Acid—AOX1—Metabolism—NME2—ovarian cancer	0.00073	0.00261	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—ERBB2—ovarian cancer	0.000721	0.00258	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—ERBB2—ovarian cancer	0.000721	0.00258	CbGpPWpGaD
Aminocaproic Acid—Pain—Paclitaxel—ovarian cancer	0.000715	0.00222	CcSEcCtD
Aminocaproic Acid—Confusional state—Docetaxel—ovarian cancer	0.000715	0.00222	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling by PDGF—MTOR—ovarian cancer	0.000712	0.00255	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—PIK3CB—ovarian cancer	0.000712	0.00255	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—PIK3CB—ovarian cancer	0.000712	0.00255	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—MTOR—ovarian cancer	0.000712	0.00255	CbGpPWpGaD
Aminocaproic Acid—Anaphylactic shock—Docetaxel—ovarian cancer	0.000709	0.0022	CcSEcCtD
Aminocaproic Acid—Oedema—Docetaxel—ovarian cancer	0.000709	0.0022	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Epirubicin—ovarian cancer	0.0007	0.00217	CcSEcCtD
Aminocaproic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	0.000699	0.0025	CbGpPWpGaD
Aminocaproic Acid—Shock—Docetaxel—ovarian cancer	0.000698	0.00217	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Docetaxel—ovarian cancer	0.000694	0.00216	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Paclitaxel—ovarian cancer	0.000689	0.00214	CcSEcCtD
Aminocaproic Acid—PLG—Selenium Micronutrient Network—IL6—ovarian cancer	0.000687	0.00246	CbGpPWpGaD
Aminocaproic Acid—PLAT—Selenium Micronutrient Network—IL6—ovarian cancer	0.000687	0.00246	CbGpPWpGaD
Aminocaproic Acid—Bradycardia—Epirubicin—ovarian cancer	0.000685	0.00213	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000684	0.00213	CcSEcCtD
Aminocaproic Acid—Renal failure—Doxorubicin—ovarian cancer	0.000682	0.00212	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling by PDGF—CDKN1B—ovarian cancer	0.000668	0.00239	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—CDKN1B—ovarian cancer	0.000668	0.00239	CbGpPWpGaD
Aminocaproic Acid—Hypotension—Docetaxel—ovarian cancer	0.000663	0.00206	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Paclitaxel—ovarian cancer	0.000661	0.00206	CcSEcCtD
Aminocaproic Acid—AOX1—Disease—BCL9—ovarian cancer	0.000661	0.00237	CbGpPWpGaD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—TP53—ovarian cancer	0.000652	0.00233	CbGpPWpGaD
Aminocaproic Acid—Agranulocytosis—Doxorubicin—ovarian cancer	0.000648	0.00201	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000646	0.00201	CcSEcCtD
Aminocaproic Acid—PLAT—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000646	0.00231	CbGpPWpGaD
Aminocaproic Acid—PLG—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000646	0.00231	CbGpPWpGaD
Aminocaproic Acid—PLG—Extracellular matrix organization—CDH1—ovarian cancer	0.000635	0.00227	CbGpPWpGaD
Aminocaproic Acid—Bradycardia—Doxorubicin—ovarian cancer	0.000634	0.00197	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling Pathways—BCL9—ovarian cancer	0.000633	0.00227	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—BCL9—ovarian cancer	0.000633	0.00227	CbGpPWpGaD
Aminocaproic Acid—Dyspnoea—Docetaxel—ovarian cancer	0.000632	0.00196	CcSEcCtD
Aminocaproic Acid—Tinnitus—Epirubicin—ovarian cancer	0.000628	0.00195	CcSEcCtD
Aminocaproic Acid—PLG—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000624	0.00223	CbGpPWpGaD
Aminocaproic Acid—PLAT—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000624	0.00223	CbGpPWpGaD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—HRAS—ovarian cancer	0.000623	0.00223	CbGpPWpGaD
Aminocaproic Acid—Hypersensitivity—Paclitaxel—ovarian cancer	0.000616	0.00192	CcSEcCtD
Aminocaproic Acid—PLG—Hemostasis—SOD1—ovarian cancer	0.000616	0.0022	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—SOD1—ovarian cancer	0.000616	0.0022	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—PTEN—ovarian cancer	0.000615	0.0022	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—PTEN—ovarian cancer	0.000615	0.0022	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—PPP2R1A—ovarian cancer	0.000613	0.00219	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—PPP2R1A—ovarian cancer	0.000613	0.00219	CbGpPWpGaD
Aminocaproic Acid—PLG—Extracellular matrix organization—MMP2—ovarian cancer	0.000611	0.00219	CbGpPWpGaD
Aminocaproic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	0.000609	0.00218	CbGpPWpGaD
Aminocaproic Acid—Pain—Docetaxel—ovarian cancer	0.000606	0.00188	CcSEcCtD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—IL6—ovarian cancer	0.000597	0.00214	CbGpPWpGaD
Aminocaproic Acid—Pruritus—Paclitaxel—ovarian cancer	0.000592	0.00184	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Docetaxel—ovarian cancer	0.000584	0.00182	CcSEcCtD
Aminocaproic Acid—Tinnitus—Doxorubicin—ovarian cancer	0.000581	0.0018	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00058	0.0018	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Paclitaxel—ovarian cancer	0.000572	0.00178	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Docetaxel—ovarian cancer	0.000561	0.00174	CcSEcCtD
Aminocaproic Acid—PLG—Platelet activation, signaling and aggregation—IL2—ovarian cancer	0.00056	0.002	CbGpPWpGaD
Aminocaproic Acid—Dizziness—Paclitaxel—ovarian cancer	0.000553	0.00172	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling by PDGF—STAT3—ovarian cancer	0.00055	0.00197	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—STAT3—ovarian cancer	0.00055	0.00197	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—NRAS—ovarian cancer	0.000549	0.00197	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—NRAS—ovarian cancer	0.000549	0.00197	CbGpPWpGaD
Aminocaproic Acid—Ill-defined disorder—Epirubicin—ovarian cancer	0.000544	0.00169	CcSEcCtD
Aminocaproic Acid—Vomiting—Paclitaxel—ovarian cancer	0.000532	0.00165	CcSEcCtD
Aminocaproic Acid—Malaise—Epirubicin—ovarian cancer	0.000529	0.00164	CcSEcCtD
Aminocaproic Acid—Rash—Paclitaxel—ovarian cancer	0.000528	0.00164	CcSEcCtD
Aminocaproic Acid—Dermatitis—Paclitaxel—ovarian cancer	0.000527	0.00164	CcSEcCtD
Aminocaproic Acid—PLG—Signaling by PDGF—MAPK3—ovarian cancer	0.000526	0.00188	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—MAPK3—ovarian cancer	0.000526	0.00188	CbGpPWpGaD
Aminocaproic Acid—Syncope—Epirubicin—ovarian cancer	0.000526	0.00163	CcSEcCtD
Aminocaproic Acid—Leukopenia—Epirubicin—ovarian cancer	0.000525	0.00163	CcSEcCtD
Aminocaproic Acid—Headache—Paclitaxel—ovarian cancer	0.000524	0.00163	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Docetaxel—ovarian cancer	0.000522	0.00162	CcSEcCtD
Aminocaproic Acid—Loss of consciousness—Epirubicin—ovarian cancer	0.000515	0.0016	CcSEcCtD
Aminocaproic Acid—Convulsion—Epirubicin—ovarian cancer	0.000508	0.00158	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000503	0.00156	CcSEcCtD
Aminocaproic Acid—Pruritus—Docetaxel—ovarian cancer	0.000502	0.00156	CcSEcCtD
Aminocaproic Acid—PLG—Signaling by PDGF—MAPK1—ovarian cancer	0.0005	0.00179	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—MAPK1—ovarian cancer	0.0005	0.00179	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—DOK1—ovarian cancer	0.0005	0.00179	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—DOK1—ovarian cancer	0.0005	0.00179	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—EGFR—ovarian cancer	0.0005	0.00179	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—EGFR—ovarian cancer	0.0005	0.00179	CbGpPWpGaD
Aminocaproic Acid—Myalgia—Epirubicin—ovarian cancer	0.000499	0.00155	CcSEcCtD
Aminocaproic Acid—Nausea—Paclitaxel—ovarian cancer	0.000497	0.00154	CcSEcCtD
Aminocaproic Acid—Discomfort—Epirubicin—ovarian cancer	0.000493	0.00153	CcSEcCtD
Aminocaproic Acid—PLG—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000492	0.00176	CbGpPWpGaD
Aminocaproic Acid—PLAT—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000492	0.00176	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—PPP1CC—ovarian cancer	0.000491	0.00176	CbGpPWpGaD
Aminocaproic Acid—Malaise—Doxorubicin—ovarian cancer	0.000489	0.00152	CcSEcCtD
Aminocaproic Acid—Syncope—Doxorubicin—ovarian cancer	0.000486	0.00151	CcSEcCtD
Aminocaproic Acid—PLG—Extracellular matrix organization—CASP3—ovarian cancer	0.000486	0.00174	CbGpPWpGaD
Aminocaproic Acid—Leukopenia—Doxorubicin—ovarian cancer	0.000485	0.00151	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Docetaxel—ovarian cancer	0.000485	0.00151	CcSEcCtD
Aminocaproic Acid—Confusional state—Epirubicin—ovarian cancer	0.000482	0.0015	CcSEcCtD
Aminocaproic Acid—Oedema—Epirubicin—ovarian cancer	0.000478	0.00149	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Epirubicin—ovarian cancer	0.000478	0.00149	CcSEcCtD
Aminocaproic Acid—Loss of consciousness—Doxorubicin—ovarian cancer	0.000477	0.00148	CcSEcCtD
Aminocaproic Acid—PLG—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	0.000476	0.0017	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—KRAS—ovarian cancer	0.000472	0.00169	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—KRAS—ovarian cancer	0.000472	0.00169	CbGpPWpGaD
Aminocaproic Acid—Shock—Epirubicin—ovarian cancer	0.000471	0.00146	CcSEcCtD
Aminocaproic Acid—AOX1—Metabolism—CYTB—ovarian cancer	0.00047	0.00168	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—PPP1CC—ovarian cancer	0.00047	0.00168	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—PPP1CC—ovarian cancer	0.00047	0.00168	CbGpPWpGaD
Aminocaproic Acid—Convulsion—Doxorubicin—ovarian cancer	0.00047	0.00146	CcSEcCtD
Aminocaproic Acid—Dizziness—Docetaxel—ovarian cancer	0.000469	0.00146	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Epirubicin—ovarian cancer	0.000468	0.00146	CcSEcCtD
Aminocaproic Acid—Myalgia—Doxorubicin—ovarian cancer	0.000462	0.00143	CcSEcCtD
Aminocaproic Acid—PLG—Extracellular matrix organization—MMP9—ovarian cancer	0.00046	0.00165	CbGpPWpGaD
Aminocaproic Acid—Discomfort—Doxorubicin—ovarian cancer	0.000456	0.00142	CcSEcCtD
Aminocaproic Acid—Vomiting—Docetaxel—ovarian cancer	0.000451	0.0014	CcSEcCtD
Aminocaproic Acid—PLAT—Hemostasis—CAV1—ovarian cancer	0.00045	0.00161	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—CAV1—ovarian cancer	0.00045	0.00161	CbGpPWpGaD
Aminocaproic Acid—PLG—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	0.00045	0.00161	CbGpPWpGaD
Aminocaproic Acid—Rash—Docetaxel—ovarian cancer	0.000447	0.00139	CcSEcCtD
Aminocaproic Acid—Hypotension—Epirubicin—ovarian cancer	0.000447	0.00139	CcSEcCtD
Aminocaproic Acid—Dermatitis—Docetaxel—ovarian cancer	0.000447	0.00139	CcSEcCtD
Aminocaproic Acid—Confusional state—Doxorubicin—ovarian cancer	0.000446	0.00139	CcSEcCtD
Aminocaproic Acid—Headache—Docetaxel—ovarian cancer	0.000444	0.00138	CcSEcCtD
Aminocaproic Acid—Oedema—Doxorubicin—ovarian cancer	0.000443	0.00138	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000443	0.00138	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000436	0.00135	CcSEcCtD
Aminocaproic Acid—Shock—Doxorubicin—ovarian cancer	0.000435	0.00135	CcSEcCtD
Aminocaproic Acid—PLG—Signaling by PDGF—PIK3CA—ovarian cancer	0.000434	0.00155	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—PIK3CA—ovarian cancer	0.000434	0.00155	CbGpPWpGaD
Aminocaproic Acid—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000433	0.00135	CcSEcCtD
Aminocaproic Acid—PLG—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	0.000428	0.00153	CbGpPWpGaD
Aminocaproic Acid—Dyspnoea—Epirubicin—ovarian cancer	0.000426	0.00133	CcSEcCtD
Aminocaproic Acid—Nausea—Docetaxel—ovarian cancer	0.000421	0.00131	CcSEcCtD
Aminocaproic Acid—Hypotension—Doxorubicin—ovarian cancer	0.000414	0.00129	CcSEcCtD
Aminocaproic Acid—AOX1—Metabolism—PPP1CC—ovarian cancer	0.000411	0.00147	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—BRIP1—ovarian cancer	0.000411	0.00147	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—PIK3CG—ovarian cancer	0.00041	0.00147	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—PIK3CG—ovarian cancer	0.00041	0.00147	CbGpPWpGaD
Aminocaproic Acid—Pain—Epirubicin—ovarian cancer	0.000409	0.00127	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000403	0.00125	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling by PDGF—HRAS—ovarian cancer	0.000401	0.00144	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—HRAS—ovarian cancer	0.000401	0.00144	CbGpPWpGaD
Aminocaproic Acid—Dyspnoea—Doxorubicin—ovarian cancer	0.000395	0.00123	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Epirubicin—ovarian cancer	0.000394	0.00122	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000391	0.00122	CcSEcCtD
Aminocaproic Acid—PLG—Signaling by PDGF—IL6—ovarian cancer	0.000384	0.00138	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—IL6—ovarian cancer	0.000384	0.00138	CbGpPWpGaD
Aminocaproic Acid—Pain—Doxorubicin—ovarian cancer	0.000378	0.00118	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Epirubicin—ovarian cancer	0.000378	0.00117	CcSEcCtD
Aminocaproic Acid—AOX1—Disease—HDAC6—ovarian cancer	0.000372	0.00133	CbGpPWpGaD
Aminocaproic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	0.000372	0.00133	CbGpPWpGaD
Aminocaproic Acid—Feeling abnormal—Doxorubicin—ovarian cancer	0.000365	0.00113	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000362	0.00112	CcSEcCtD
Aminocaproic Acid—PLG—Hemostasis—PIK3CD—ovarian cancer	0.00036	0.00129	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—PIK3CD—ovarian cancer	0.00036	0.00129	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—HDAC6—ovarian cancer	0.000356	0.00128	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—HDAC6—ovarian cancer	0.000356	0.00128	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—AKT1—ovarian cancer	0.000355	0.00127	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—AKT1—ovarian cancer	0.000355	0.00127	CbGpPWpGaD
Aminocaproic Acid—Hypersensitivity—Epirubicin—ovarian cancer	0.000352	0.0011	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Doxorubicin—ovarian cancer	0.00035	0.00109	CcSEcCtD
Aminocaproic Acid—Pruritus—Epirubicin—ovarian cancer	0.000338	0.00105	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Epirubicin—ovarian cancer	0.000327	0.00102	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Doxorubicin—ovarian cancer	0.000326	0.00101	CcSEcCtD
Aminocaproic Acid—AOX1—Disease—XIAP—ovarian cancer	0.000323	0.00116	CbGpPWpGaD
Aminocaproic Acid—Dizziness—Epirubicin—ovarian cancer	0.000316	0.000983	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling Pathways—YAP1—ovarian cancer	0.000315	0.00113	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—YAP1—ovarian cancer	0.000315	0.00113	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—SMARCA4—ovarian cancer	0.000314	0.00113	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—PIK3CB—ovarian cancer	0.000314	0.00113	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—PIK3CB—ovarian cancer	0.000314	0.00113	CbGpPWpGaD
Aminocaproic Acid—Pruritus—Doxorubicin—ovarian cancer	0.000313	0.000973	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling Pathways—XIAP—ovarian cancer	0.000309	0.00111	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—XIAP—ovarian cancer	0.000309	0.00111	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—EREG—ovarian cancer	0.000307	0.0011	CbGpPWpGaD
Aminocaproic Acid—Vomiting—Epirubicin—ovarian cancer	0.000304	0.000945	CcSEcCtD
Aminocaproic Acid—PLG—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	0.000304	0.00109	CbGpPWpGaD
Aminocaproic Acid—Diarrhoea—Doxorubicin—ovarian cancer	0.000303	0.000941	CcSEcCtD
Aminocaproic Acid—Rash—Epirubicin—ovarian cancer	0.000302	0.000937	CcSEcCtD
Aminocaproic Acid—Dermatitis—Epirubicin—ovarian cancer	0.000301	0.000936	CcSEcCtD
Aminocaproic Acid—PLG—Signaling Pathways—SMARCA4—ovarian cancer	0.000301	0.00108	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—SMARCA4—ovarian cancer	0.000301	0.00108	CbGpPWpGaD
Aminocaproic Acid—Headache—Epirubicin—ovarian cancer	0.0003	0.000931	CcSEcCtD
Aminocaproic Acid—PLG—Signaling Pathways—EREG—ovarian cancer	0.000294	0.00105	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—EREG—ovarian cancer	0.000294	0.00105	CbGpPWpGaD
Aminocaproic Acid—Dizziness—Doxorubicin—ovarian cancer	0.000293	0.000909	CcSEcCtD
Aminocaproic Acid—PLAT—Hemostasis—IL2—ovarian cancer	0.000289	0.00103	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—IL2—ovarian cancer	0.000289	0.00103	CbGpPWpGaD
Aminocaproic Acid—PLG—Metabolism of proteins—MMP2—ovarian cancer	0.000286	0.00102	CbGpPWpGaD
Aminocaproic Acid—Nausea—Epirubicin—ovarian cancer	0.000284	0.000883	CcSEcCtD
Aminocaproic Acid—Vomiting—Doxorubicin—ovarian cancer	0.000281	0.000874	CcSEcCtD
Aminocaproic Acid—Rash—Doxorubicin—ovarian cancer	0.000279	0.000867	CcSEcCtD
Aminocaproic Acid—Dermatitis—Doxorubicin—ovarian cancer	0.000279	0.000866	CcSEcCtD
Aminocaproic Acid—Headache—Doxorubicin—ovarian cancer	0.000277	0.000862	CcSEcCtD
Aminocaproic Acid—AOX1—Metabolism—YAP1—ovarian cancer	0.000276	0.000988	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—PGR—ovarian cancer	0.000275	0.000986	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—PGR—ovarian cancer	0.000275	0.000986	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—FASN—ovarian cancer	0.000268	0.000961	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—PARP1—ovarian cancer	0.000267	0.000957	CbGpPWpGaD
Aminocaproic Acid—Nausea—Doxorubicin—ovarian cancer	0.000263	0.000817	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling Pathways—PARP1—ovarian cancer	0.000256	0.000917	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—PARP1—ovarian cancer	0.000256	0.000917	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—SLC2A1—ovarian cancer	0.000255	0.000913	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—VEGFA—ovarian cancer	0.000245	0.000878	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—VEGFA—ovarian cancer	0.000245	0.000878	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—NRAS—ovarian cancer	0.000242	0.000867	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—NRAS—ovarian cancer	0.000242	0.000867	CbGpPWpGaD
Aminocaproic Acid—PLG—Metabolism of proteins—CXCL8—ovarian cancer	0.000237	0.00085	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—MAPK3—ovarian cancer	0.000232	0.000831	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—MAPK3—ovarian cancer	0.000232	0.000831	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—FASN—ovarian cancer	0.000225	0.000805	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—SLC5A5—ovarian cancer	0.000221	0.000792	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—MAPK1—ovarian cancer	0.000221	0.00079	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—MAPK1—ovarian cancer	0.000221	0.00079	CbGpPWpGaD
Aminocaproic Acid—PLG—Metabolism of proteins—CTNNB1—ovarian cancer	0.000219	0.000785	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—PPP2R1A—ovarian cancer	0.000217	0.000776	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—SLC2A1—ovarian cancer	0.000214	0.000765	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—KRAS—ovarian cancer	0.000208	0.000746	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—KRAS—ovarian cancer	0.000208	0.000746	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—PPP2R1A—ovarian cancer	0.000208	0.000744	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—PPP2R1A—ovarian cancer	0.000208	0.000744	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—CYP1B1—ovarian cancer	0.000205	0.000733	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—PIK3CA—ovarian cancer	0.000192	0.000686	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—PIK3CA—ovarian cancer	0.000192	0.000686	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—TP53—ovarian cancer	0.000185	0.000663	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—TP53—ovarian cancer	0.000185	0.000663	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—PPP2R1A—ovarian cancer	0.000182	0.00065	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—HRAS—ovarian cancer	0.000177	0.000635	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—HRAS—ovarian cancer	0.000177	0.000635	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—TERT—ovarian cancer	0.000172	0.000617	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—ABCB1—ovarian cancer	0.000169	0.000604	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—TYMS—ovarian cancer	0.000166	0.000593	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—TERT—ovarian cancer	0.000165	0.000591	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—TERT—ovarian cancer	0.000165	0.000591	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—CAV1—ovarian cancer	0.000159	0.000571	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—AKT1—ovarian cancer	0.000156	0.00056	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—AKT1—ovarian cancer	0.000156	0.00056	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—CAV1—ovarian cancer	0.000153	0.000546	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—CAV1—ovarian cancer	0.000153	0.000546	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—IL6ST—ovarian cancer	0.000151	0.000541	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—ESR1—ovarian cancer	0.000147	0.000527	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—ESR1—ovarian cancer	0.000147	0.000527	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—APC—ovarian cancer	0.000145	0.00052	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—IL6ST—ovarian cancer	0.000145	0.000518	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—IL6ST—ovarian cancer	0.000145	0.000518	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—PIK3CG—ovarian cancer	0.000139	0.000498	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—PIK3CG—ovarian cancer	0.000139	0.000498	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—APC—ovarian cancer	0.000139	0.000498	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—APC—ovarian cancer	0.000139	0.000498	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—CAV1—ovarian cancer	0.000133	0.000478	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—PIK3CD—ovarian cancer	0.000128	0.000457	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—PIK3CD—ovarian cancer	0.000122	0.000438	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—PIK3CD—ovarian cancer	0.000122	0.000438	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—PIK3CG—ovarian cancer	0.000122	0.000435	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—ERBB2—ovarian cancer	0.000113	0.000404	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—PIK3CB—ovarian cancer	0.000111	0.000398	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—MTOR—ovarian cancer	0.000111	0.000398	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—ERBB2—ovarian cancer	0.000108	0.000386	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—ERBB2—ovarian cancer	0.000108	0.000386	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—PIK3CD—ovarian cancer	0.000107	0.000383	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—PIK3CB—ovarian cancer	0.000107	0.000381	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—PIK3CB—ovarian cancer	0.000107	0.000381	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—MTOR—ovarian cancer	0.000107	0.000381	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—MTOR—ovarian cancer	0.000107	0.000381	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—CDKN1B—ovarian cancer	0.000104	0.000374	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—CXCL8—ovarian cancer	0.000102	0.000367	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—CXCL8—ovarian cancer	0.000102	0.000367	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—CDKN1B—ovarian cancer	9.99e-05	0.000358	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—CDKN1B—ovarian cancer	9.99e-05	0.000358	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—CTNNB1—ovarian cancer	9.86e-05	0.000353	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—CASP3—ovarian cancer	9.8e-05	0.000351	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—CASP3—ovarian cancer	9.8e-05	0.000351	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—IL2—ovarian cancer	9.78e-05	0.00035	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—IL2—ovarian cancer	9.78e-05	0.00035	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—PTEN—ovarian cancer	9.61e-05	0.000344	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—CCND1—ovarian cancer	9.53e-05	0.000341	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—CCND1—ovarian cancer	9.53e-05	0.000341	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—CTNNB1—ovarian cancer	9.44e-05	0.000338	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—CTNNB1—ovarian cancer	9.44e-05	0.000338	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—PIK3CB—ovarian cancer	9.31e-05	0.000334	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—MMP9—ovarian cancer	9.26e-05	0.000332	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—MMP9—ovarian cancer	9.26e-05	0.000332	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—PTEN—ovarian cancer	9.2e-05	0.00033	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—PTEN—ovarian cancer	9.2e-05	0.00033	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—STAT3—ovarian cancer	8.59e-05	0.000308	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—NRAS—ovarian cancer	8.57e-05	0.000307	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—VEGFA—ovarian cancer	8.31e-05	0.000298	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—VEGFA—ovarian cancer	8.31e-05	0.000298	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—STAT3—ovarian cancer	8.23e-05	0.000295	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—STAT3—ovarian cancer	8.23e-05	0.000295	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—NRAS—ovarian cancer	8.21e-05	0.000294	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—NRAS—ovarian cancer	8.21e-05	0.000294	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—MAPK3—ovarian cancer	8.21e-05	0.000294	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—PTEN—ovarian cancer	8.05e-05	0.000288	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—MYC—ovarian cancer	7.99e-05	0.000286	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—MAPK3—ovarian cancer	7.86e-05	0.000282	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—MAPK3—ovarian cancer	7.86e-05	0.000282	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—MAPK1—ovarian cancer	7.81e-05	0.00028	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—EGFR—ovarian cancer	7.81e-05	0.00028	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—MYC—ovarian cancer	7.65e-05	0.000274	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—MYC—ovarian cancer	7.65e-05	0.000274	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—MAPK1—ovarian cancer	7.48e-05	0.000268	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—MAPK1—ovarian cancer	7.48e-05	0.000268	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—EGFR—ovarian cancer	7.48e-05	0.000268	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—EGFR—ovarian cancer	7.48e-05	0.000268	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—KRAS—ovarian cancer	7.38e-05	0.000264	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—KRAS—ovarian cancer	7.07e-05	0.000253	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—KRAS—ovarian cancer	7.07e-05	0.000253	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—PIK3CA—ovarian cancer	6.78e-05	0.000243	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—PIK3CA—ovarian cancer	6.49e-05	0.000233	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—PIK3CA—ovarian cancer	6.49e-05	0.000233	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—TP53—ovarian cancer	6.28e-05	0.000225	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—TP53—ovarian cancer	6.28e-05	0.000225	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—HRAS—ovarian cancer	6.27e-05	0.000225	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—HRAS—ovarian cancer	6.01e-05	0.000215	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—HRAS—ovarian cancer	6.01e-05	0.000215	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—IL6—ovarian cancer	6e-05	0.000215	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—IL6—ovarian cancer	5.75e-05	0.000206	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—IL6—ovarian cancer	5.75e-05	0.000206	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—PIK3CA—ovarian cancer	5.68e-05	0.000203	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—AKT1—ovarian cancer	5.54e-05	0.000198	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—AKT1—ovarian cancer	5.3e-05	0.00019	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—AKT1—ovarian cancer	5.3e-05	0.00019	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—AKT1—ovarian cancer	4.64e-05	0.000166	CbGpPWpGaD
